| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 798 | 1,142 | 594 | 914 | | Cost of Revenue | 691 | 929 | 600 | 875 | | | Gross Profit | 107 | 213 | (6) | 39 | | | Operating Expenses | | Research Development | 273 | 150 | 119 | 130 | | Selling General and Administrative | 758 | 1,311 | 648 | 746 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (924) | (1,248) | (773) | (837) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 21 | | Earnings Before Interest And Taxes | (1,869) | (1,248) | (773) | (816) | | Interest Expense | (951) | 792 | 159 | 6 | | Income Before Tax | (918) | (2,040) | (932) | (822) | | Income Tax Expense |
-
|
-
|
-
| (196) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (918) | (2,040) | (932) | (626) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (918) | (2,040) | (932) | (626) | | Preferred Stock And Other Adjustments |
-
| (1,518) | (970) |
-
| | | Net Income Applicable To Common Shares | ($918) | ($3,558) | ($1,902) | ($626) |
|
0.00% Nasdaq 
0.21%
Income Statement
